More Stem Cell News

Stem cells have been used to help reverse paralysis in rats.

The study, headed up by Miodrag Stojkovic, deputy director and head of the Cellular Reprogramming Laboratory at Centro de Investigacion Principe Felipe in Spain, involved transplanting so-called progenitor stem cells from the lining of rats’ spinal cords into rodents with serious spinal cord injuries.

The rats recovered significant motor activity one week after injury, Stojkovic and his co-authors wrote in the Jan. 27 early online edition of the journal Stem Cells.

The researchers say the new rat results “open a new window on spinal cord regenerative strategies.”

These are great results, of course. But we all know what’s going to happen now. Those who are motivated by magic will claim this somehow proves embryonic stem cells are not needed. It, obviously, does not, but some people give extra respect to certain blobs of differentiated cells. The reason why is jarbled and arbitrary. On the upside, however, is the fact that the U.S. no longer has an anti-science administration in place, so the cries of the religious aren’t going to be heard quite so well, at least on this subject.

Obama

Oh, right. In every other ceremonial service from inauguration day.

Embyonic stem cells

The FDA has approved a study which will inject embyonic stem cells into humans.

The Geron corporation announce the approval today. The therapy used in the study is designed to treat spinal cord injuries by injecting stem cells — which are able to transform into the many different types of cells we need in our bodies — directly into the patients’ spinal cords.

The U.S. Food and Drug Administration (FDA) granted clearance of the company’s application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.

“This marks the beginning of what is potentially a new chapter in medical therapeutics – one that reaches beyond pills to a new level of healing: the restoration of organ and tissue function achieved by the injection of healthy replacement cells,” said Geron’s president and CEO. Dr. Thomas B. Okarma.

“The neurosurgical community is very excited by this new approach to treating devastating spinal cord injury,” said Dr. Richard Fessler, a professor of neurological surgery at the Feinberg School of Medicine at Northwestern University.

While, according to the article this doesn’t have much to do with the recent shift from hating science and its beauty to embracing truth (the shift from Bush to Obama), it is pretty exciting. Stem cells are wonderful things. If some major theraputic treatment does not arise out of these cells, I’ll be awfully surprised (and the scientific community). I think it may be safe enough to say if many treatments do not come from stem cells, the surprise will be huge around the world. These far-from-conscious cells are the future of medical science.